CULLINAN THERAPEUTICS INC. - COMMON STOCK
9,8900
12-февраля-25 15:00:18
15 мин. задержка
Акции
+0,0800
+0,82%
Сегодняшний диапазон
9,5000 - 9,9500
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Cullinan Oncology to Provide Clinical Update for CLN-081 in NSCLC EGFR Exon 20 Patients
13 дек 2021 06:00:00 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in the Evercore ISI 4th Annual HealthconX Conference
22 ноя 2021 11:37:10 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
09 ноя 2021 05:45:00 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology Appoints Nadim Ahmed as Chief Executive Officer
18 окт 2021 06:00:00 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Upcoming Investor Conferences
08 сен 2021 15:01:00 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
10 авг 2021 05:30:00 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in the 41st Annual Canaccord Genuity Growth Conference
05 авг 2021 15:05:00 Источник Nasdaq GlobeNewswire
-
29 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
07 июн 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
04 июн 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology Announces Management Transition
21 май 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology to Provide CLN-081 Clinical Update at ASCO 2021
19 май 2021 16:00:00 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology Reports First Quarter 2021 Financial Results
14 май 2021 05:30:00 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology, Inc. to Participate in the 20th Annual Needham Virtual Healthcare Conference
07 апр 2021 09:08:07 Источник Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Full Year 2020 Financial Results and Business Highlights
30 мар 2021 05:15:00 Источник Nasdaq GlobeNewswire